Clinical Factors Predicting Better Survival Outcome for Pulmonary Metastasectomy of Hepatocellular Carcinoma | Zendy

Tse-Ming Kuo | Zendy; KaiMing Chang | Zendy; Tsun-I Cheng | Zendy; Kuo-Jang Kao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Factors Predicting Better Survival Outcome for Pulmonary Metastasectomy of Hepatocellular Carcinoma

Author(s) -

Tse-Ming Kuo,

KaiMing Chang,

Tsun-I Cheng,

Kuo-Jang Kao

Publication year - 2017

Publication title -

liver cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.916

H-Index - 34

eISSN - 2235-1795

pISSN - 1664-5553

DOI - 10.1159/000477134

Subject(s) - metastasectomy , medicine , metastasis , proportional hazards model , hepatocellular carcinoma , lung , oncology , survival analysis , exact test , radiology , surgery , cancer

In patients with lung metastasis of hepatocellular carcinoma (HCC), it remains uncertain how a better survival outcome can be predicted after metastasectomy. This study aims to identify clinical factors that may be used to guide patient selection for such a therapeutic modality. A total of 28 patients who received pulmonary metastasectomy for HCC between 1993 and 2012 were identified. All relevant clinical factors were extracted from medical records up to September 2015. Patients were classified into high- and low-risk groups according to survival outcome after metastasectomy. All pertinent clinical factors were analyzed for correlation with survival outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research